insights_auto
Prečo akcie NOTA klesli 2,14%?
Preskúmať podrobnejšiechevron_right
NOTA:FRA
Novartis
137,00 €
arrow_downward
-2,14%(-3,00) 1 d.
20. 11., 22:00:00 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre NOTA…
Otvoriť
137,00 €
Vysoká
137,00 €
Nízka
137,00 €
Trh. kap.
305,32 mld.
Priem. obj.
8,00
Objem
0,00
Max. za 52 týž.
146,00 €
Min. za 52 týž.
105,50 €
Počet zamestnancov
75 tis.
Otvoriť
137,00 €
Vysoká
137,00 €
Nízka
137,00 €
Trh. kap.
305,32 mld.
Priem. obj.
8,00
Objem
0,00
Max. za 52 týž.
146,00 €
Min. za 52 týž.
105,50 €
Počet zamestnancov
75 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
ad-hoc-news.de
·
pred 58 minútami
Novartis stock: 5% growth outlook and Cosentyx FDA approval
The Globe and Mail
·
pred 4 hodinami
Barclays Remains a Hold on Novartis AG (NOVN)
Yahoo Finance
·
pred 23 hodinami
Novartis CEO leans on surge of pipeline readouts to quell growth fears
marketscreener.com
·
pred 1 dňom
RBC: Hopes for Higher Novartis Midterm Sales Growth 'Unrealistic,' Share Reaction 'Overdone'
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Informácie o subjekte Novartis
Generálny riaditeľVasant Narasimhan
Zamestnanci75,3 tis.
Dátum založenia7. 3. 1996
Hlavné sídloBazilej, Bazilej-mesto, Švajčiarsko
OdvetvieHealth Care
Odvetvie-
Webnovartis.com